pembrolizumab,tislelizumab,lenvatinib,sorafenib
beigene,eisai,merck,bayer,novartis
['rationale301', 'hcc', 'leap-002', 'lenva']
#esmo2022 hot off the press! so what have we learned from the hcc lbas? advanced disease patients have an improved os on tkis alone (lenvatinibe w/ best seen yet os curve!) and combination therapies are a thing and should stay that way! #leap-002 #rationale301
Maria Cecília Mathias - Medical Oncologist and GI Fellow @grupoOncoclínicas ?? Former Oncology Fellow @ ICESP  | ?? Baiana ??????and proud of it! ????